Navidea Biopharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.50
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.00
|
-0.25
|
0.00
|
0.00%
|
|
2022-06-30
|
0.00
|
-0.10
|
0.00
|
0.00%
|
|
2022-03-31
|
0.00
|
-0.10
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.03
|
-0.12
|
-0.09
|
-300.00%
|
|
2021-09-30
|
-0.11
|
-0.08
|
0.03
|
27.27%
|
|
2021-06-30
|
-0.08
|
-0.09
|
-0.01
|
-12.50%
|
|
2021-03-31
|
-0.08
|
-0.11
|
-0.03
|
-37.50%
|
|
2020-12-31
|
-0.12
|
-0.11
|
0.01
|
8.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.45
|
|
2021-12-31
|
-0.40
|
|
2020-12-31
|
-0.48
|
|
2019-12-31
|
-0.80
|
|
2018-12-31
|
-1.24
|
|
2017-12-31
|
-1.42
|
|
2016-12-31
|
-1.61
|
|
2015-12-31
|
-0.18
|
|
2014-12-31
|
-2.70
|
|
2013-12-31
|
-6.80
|
|
2012-12-31
|
-5.80
|
|
2011-12-31
|
-4.40
|
|
2010-12-31
|
-14.60
|
|
2009-12-31
|
-10.92
|
|
2008-12-31
|
-1.55
|
|
2007-12-31
|
-1.60
|
|
2006-12-31
|
-1.64
|
|
2005-12-31
|
-1.60
|
|
2004-12-31
|
-1.29
|
|
2003-12-31
|
-0.89
|
|
2002-12-31
|
-1.65
|
|
2001-12-31
|
-20.76
|
|
1997-12-31
|
-20.60
|
|
1996-12-31
|
-14.40
|
|
1995-12-31
|
-10.60
|